AI-generated summary
This review examines laser therapy for androgenetic alopecia, covering device history, proposed mechanisms, and clinical evidence for low-level laser therapy and fractional lasers. The authors report that studies of these monotherapies showed improvement in hair markers from baseline, but these studies had small samples and some concerns about procedural design. The authors conclude that evidence of efficacy is limited by the lack of large, high-quality trials.
- Who or what was studied
- Individuals with androgenetic alopecia (male and female pattern hair loss)
- Limits stated in the abstract
- The abstract notes small sample sizes, concerns about procedural design and risk of bias, and a lack of large-scale, high-quality trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Androgenetic alopecia, Risk of bias, Inflammation, Sample size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.